Nanocarriers in therapy of infectious and inflammatory diseases. - Wikidata - wikimedia - TriplyDB

Nanocarriers in therapy of infectious and inflammatory diseases.

Nanocarriers in therapy of infectious and inflammatory diseases.

http://www.wikidata.org/entity/Q38354723

about

Destruction of Opportunistic Pathogens via Polymer Nanoparticle-Mediated Release of Plant-Based Antimicrobial Payloads.Therapeutic Potential of Delivering Arsenic Trioxide into HPV-Infected Cervical Cancer Cells Using Liposomal Nanotechnology Microparticulate/Nanoparticulate Powders of a Novel Nrf2 Activator and an Aerosol Performance Enhancer for Pulmonary Delivery Targeting the Lung Nrf2/Keap-1 Pathway.Oxidative stress by inorganic nanoparticles.Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA.Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy.Recent advances in liposome surface modification for oral drug delivery.Encapsulation of Anticancer Drugs (5-Fluorouracil and Paclitaxel) into Polycaprolactone (PCL) Nanofibers and In Vitro Testing for Sustained and Targeted Therapy.Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance.Nanoparticle Delivery of Artesunate Enhances the Anti-tumor Efficiency by Activating Mitochondria-Mediated Cell Apoptosis.Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.Temperature-induced structural transitions in self-assembling magnetic nanocolloids.

P2860

Q33808672-E31559C4-699A-45B8-A034-BC82995CD153 Q36594617-D83FE1AF-816F-4550-AD51-2D8D76318AFE Q37354043-E79EFC09-344B-4BA2-95FE-940889C1580D Q38584750-1E19D7F4-7381-4680-987D-73B051A8971B Q38641628-8C71351F-9AB2-40F7-BC3C-C10EB999E401 Q38787937-F1A1407C-C0B9-4DAB-AC51-E5261FD14C2D Q38807276-FFA7D9A2-F9AF-4B47-95D1-6305435C9F12 Q41507703-DFDF6FF5-61E0-4C0C-90BA-69E6794F9F72 Q41836725-734AEE59-04AF-4555-8332-F1D22E763757 Q42207079-C0FE9DF6-BE8D-49B8-ADD3-257094FAD8D6 Q44143118-24009495-C8C9-4BB7-B565-3311C68B67EA Q50966719-3E6436E4-0F50-4EEE-B676-BF79D41DC7E1

P2860

Nanocarriers in therapy of infectious and inflammatory diseases.

http://www.wikidata.org/entity/Q38354723

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Nanocarriers in therapy of infectious and inflammatory diseases.

@en

type

label

Nanocarriers in therapy of infectious and inflammatory diseases.

@en

prefLabel

Nanocarriers in therapy of infectious and inflammatory diseases.

@en

P1433

Q38354723-AAB5A999-6748-4E6E-A275-6ECFBB02F4FA

P1476

Q38354723-CBF29F08-2E45-4916-8FCB-68519556D6DD

P2093

Q38354723-4C406102-A779-4BD8-B923-90CC4CA9FE4A

Q38354723-69BAE1DD-631E-4C0C-BBFE-0E87DAB743B3

Q38354723-6B456674-3595-43D1-BCE7-48340A9649D6

Q38354723-CC161B35-A603-467C-A4A8-533B502F5527

Q38354723-EDD83285-0567-45EE-8046-C6BD179AF6E0

P2860

Q38354723-01274713-84BB-4D53-8C37-DA7F27AD71FA

Q38354723-03E726E1-F597-44BB-A2D3-BA35DCEBBAD3

Q38354723-08EFD8D5-D8DF-4718-A81D-C608321031D3

Q38354723-0D2CE62A-52BB-40B5-83C1-7B785F8E7721

Q38354723-0D9C2173-0C98-4EF3-87E5-32D459A025B0

Q38354723-0F8CEC51-712F-4F30-B12A-26EDED0D69F3

Q38354723-17A35379-F790-4A2C-A569-9928162DB925

Q38354723-1A487303-0E87-4544-9400-34C8CD6168D1

Q38354723-1A5DF2AD-079B-4C12-8678-330C61366186

Q38354723-21071A9B-9F76-4531-A3EB-CE18A8473CA8

P304

Q38354723-7DF3C093-1251-4FAD-914C-520EB2DFFC2D

P31

Q38354723-EC30789D-0C05-4B95-9D13-32CBABE0997B

P356

Q38354723-38F80C2E-F060-498E-A64B-88FA3627F6A1

P407

Q38354723-F9AF6235-02A1-4ED1-BD5A-A0D002878B92

P433

Q38354723-90BD129C-3245-4EE4-A004-E2758FB213FA

P478

Q38354723-E6D734EA-EAE5-4925-819A-86861F7587AF

P50

Q38354723-D7038FDC-0730-4A94-B0AD-5C31471E1561

P577

Q38354723-B7E59C9A-3718-4AB7-A8BB-63F8CC6BAF64

P5875

Q38354723-469798F6-1D03-4E32-8690-3A244F781E40

P698

Q38354723-3F5D27AE-04B8-4EF3-8135-01D9807A5730

P921

Q38354723-B991F752-3B93-4126-AE09-1315196E0691

Q38354723-BBA215AE-1F84-41EB-B513-7C97C34F3EBA

P356

P1433

P1476

Nanocarriers in therapy of infectious and inflammatory diseases.

@en

P2093

Chenxu Yu

http://www.w3.org/2001/XMLSchema#string

Haichun Li

http://www.w3.org/2001/XMLSchema#string

Haisheng Peng

http://www.w3.org/2001/XMLSchema#string

Qun Wang

http://www.w3.org/2001/XMLSchema#string

Ufuoma Ikoba

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid and simultaneous detection of human hepatitis B virus and hepatitis C virus antibodies based on a protein chip assay using nano-gold immunological amplification and silver staining method.

Anti-HIV-1 nanotherapeutics: promises and challenges for the future

Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.

Melanoma Differentiation-Associated Gene 5 (MDA5) Is Involved in the Innate Immune Response to Paramyxoviridae Infection In Vivo

Synthesis of nanoparticles in the gas phase for electronic, optical and magnetic applications—a review

Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.

Progress in antiretroviral drug delivery using nanotechnology

A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Biomimetic synthesis and patterning of silver nanoparticles.

In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

P304

4291-4305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C4NR07682F

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Cathy L. Miller

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272101447

http://www.w3.org/2001/XMLSchema#string

P698

25680099

http://www.w3.org/2001/XMLSchema#string

P921